New research found over a quarter of children with treatment-refractory epilepsy sustained treatment response to CBD over four years.
FDA Approves Expanded Indication for Cerliponase Alfa to Treat CLN2 Disease in Children Under 3 Years
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
Endo Voluntarily Recalls One Lot of Clonazepam Tablets Following Mislabeling Error
Special Episode: FDA Approves Diazepam Buccal Film for Pediatric Seizures
NeurologyLive® Brain Games: July 21, 2024
NeurologyLive® Friday 5 — July 19, 2024